Completed OBSERVATIONAL NCT00507104

Pituitary Functions After Traumatic Brain Injury (TBI) and/or Subarachnoid Hemorrhage (SAH)

Prospective Longitudinal Study on Pituitary Functions After TBI and/or SAH

Sponsor: Pfizer

Conditions Hypopituitarism Subarachnoid Hemorrhage Traumatic Brain Injury

Updated 6 times since 2017 Last updated: Dec 10, 2020 Started: Sep 30, 2006 Primary completion: Nov 30, 2008 Completion: Nov 30, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00507104, this observational or N/A phase trial focuses on Hypopituitarism and Subarachnoid Hemorrhage and remains completed. Sponsored by Pfizer, it has been updated 6 times since 2006, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed

Status: Unknown Status → Completed
Jun 2018 — Jan 2021 [monthly]

Unknown Status
Apr 2018 — Jun 2018 [monthly]

Unknown Status

Phase: NA → None

▶ Show 1 earlier version

Jan 2017 — Apr 2018 [monthly]

Unknown Status NA

First recorded

Sep 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Pfizer
University of Erlangen-Nürnberg Medical School

Data source: University of Erlangen-Nürnberg Medical School

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Erlangen, Germany